| Biography | Dr. Keith Haddaway, a registered patent attorney, practices all aspects of intellectual property law. He focuses on assisting clients in patenting, protecting and commercializing inventions in a broad range of technical areas including life sciences such as pharmaceuticals, nutraceuticals, diagnostic compounds and methods, cosmetics, and medical devices; commercial chemistry, for example, coatings, catalysts, chemical processes, and petroleum additives; mechanical devices; and designs . Dr. Haddaway regularly counsels clients regarding worldwide portfolio management and strategic development, licensing, and litigation. He prepares and prosecutes patent applications and represents clients in appeals and interferences before the U.S. Patent and Trademark Office. Dr. Haddaway assists clients in structuring, drafting and negotiating licenses, partnering agreements and joint development arrangements. Dr. Haddaway's experience includes complex patent litigation involving multi-million dollar pharmaceutical compounds. He has also litigated patents in the optical disc industry. He has prepared patentability opinions, patent infringement and freedom to operate opinions. Dr. Haddaway brings more than 10 years basic and applied chemical research experience to his practice. His research activities in the areas of organic photochemistry, color additive technology and chemical defense have provided in-depth knowledge of organic synthesis, chemical analysis and analytical methods development. Dr. Haddaway has extensive knowledge of commercial chemicals gained from the review of chemicals for the EPA under the Toxic Substances Control Act (TSCA). Dr. Haddaway also has several years of experience teaching at the college level. The combination of Dr. Haddaway's scientific, chemical, educational and legal background enables him to understand and analyze patentable inventions, and to procure and defend intellectual property rights for his clients. His experience allows him to understand and assist clients with the complex legal and scientific issues that arise at the intersection of science and law. Representative Clients Dr. Haddaway's clients include research institutions, small start ups to mid-sized companies, established pharmaceutical companies, and manufacturers of drugs, dietary supplements, pharmaceutical compositions, cosmetics and devices in the United States and abroad. He works with foreign companies and law firms in a broad range of technologies. Significant Matters Dr. Haddaway assists clients in developing national and international strategies for worldwide protection of intellectual property rights. He counsels clients in making decisions regarding how to best integrate intellectual property into an overall business strategy. He also assists clients with disputes involving the intellectual property rights of others. Dr. Haddaway aids clients in the development and protection of intellectual property related to new pharmacological and diagnostic methods and other inventions with significant commercial potential. Industries Dietary Supplements, Cosmetics and Functional Foods Life Sciences Nanotechnology Pharmaceuticals Research Institutions News December 19, 2005, Venable LLP Promotes Twelve to Partner Publications Dr. Haddaway has published several articles in photochemistry and kinetics of phosphate ester decomposition. January 2012, IP Buzz - January 2012
Meaghan Hemmings Kent, Elissa Brockbank Reese, Clifton E. McCann, Janet F. Satterthwaite, Jeffrey D. Knowles, Peter Curtin, Lars H. Genieser, Ph.D., James E. Nelson, Keith G. Haddaway, Ph.D., Marcella Ballard, Justin E. Pierce, Roger A. Colaizzi
IP Buzz December 15, 2011, Use of Project Status Reports for Patent Application Deadlines
Keith G. Haddaway, Ph.D.
ECN.com September 8, 2011, The Federal Circuit's Evolving Obviousness Analysis
Keith G. Haddaway, Ph.D.
IP Buzz September 22, 2009, Hope for Biotech Claims in view of In re Bilski?
Michael E. Nelson, Ph.D., Keith G. Haddaway, Ph.D. December 2008, IP News and Comment - December 2008
Ryan M. Flandro, Michael A. Gollin, Keith G. Haddaway, Ph.D., Frederick M. Joyce, Martin L. Saad, Janet F. Satterthwaite, Meaghan Hemmings Kent
IP Buzz April 2008, IP News and Comment - April 2008
Keith G. Haddaway, Ph.D., Lars H. Genieser, Ph.D., Ryan M. Flandro, Henry J. Daley, Ph.D.
IP Buzz April 2008, Patent Prosecution in the International Phase: An Advance Bite at the Apple?
Keith G. Haddaway, Ph.D., Lars H. Genieser, Ph.D.
IP Buzz February 2008, IP News & Comment - February 2008
Michael A. Gollin, Keith G. Haddaway, Ph.D., Frederick M. Joyce, David R. Warner
IP Buzz 2006, Intellectual Property Protection: Avoiding Loss of Trade Secrets
Keith G. Haddaway, Ph.D., Clifton E. McCann October 11, 2005, Drawing the Line: Patentable v. Unpatentable Ideas in Water Treatment
Clifton E. McCann, Keith G. Haddaway, Ph.D. December 1, 2000, The American Inventors Protection Act Accelerates Patent Prosecution
Michael A. Gollin, Keith G. Haddaway, Ph.D. Events/Speaking Engagements Dr. Haddaway has presented research results at national and international conferences. Dr. Haddaway has also presented at Venable's seminars for the Bioscience industry. Past Events March 20, 2009, Johns Hopkins University's Research Administration Committee Meeting
Keith G. Haddaway, Ph.D. October 21, 2007 - October 25, 2007, 2007 International Water Conference
Keith G. Haddaway, Ph.D., Clifton E. McCann June 27, 2006, The 1st DC Area IP Docketing Forum
Keith G. Haddaway, Ph.D. October 9, 2005 - October 13, 2005, International Water Conference
Clifton E. McCann, Keith G. Haddaway, Ph.D. |